Terminated PHASE4 INTERVENTIONAL 3-arm NCT00975416

Oxytocin and Cognitive Behavioral Therapy in Drug Dependence

Sponsor: National Institute on Drug Abuse (NIDA)

Interventions Cognitive Behavioral Therapy Intranasal Oxytocin Placebo

Updated 10 times since 2017 Last updated: Oct 19, 2015 Started: Nov 30, 2008 Primary completion: Apr 30, 2013 Completion: Apr 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

This trial was terminated. No reason was provided.

Other terminated trials from National Institute on Drug Abuse (NIDA)

See all terminations from National Institute on Drug Abuse (NIDA)

Listed as NCT00975416, this PHASE4 trial focuses on Drug Dependence and remains terminated or withdrawn. Sponsored by National Institute on Drug Abuse (NIDA), it has been updated 10 times since 2008, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE4
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE4
Dec 2021 — Jul 2024 [monthly]

Terminated PHASE4
Jan 2021 — Dec 2021 [monthly]

Terminated PHASE4
Nov 2020 — Jan 2021 [monthly]

Terminated PHASE4

▶ Show 5 earlier versions

Jun 2018 — Nov 2020 [monthly]

Terminated PHASE4
May 2018 — Jun 2018 [monthly]

Terminated PHASE4
Aug 2017 — May 2018 [monthly]

Terminated PHASE4
Feb 2017 — Aug 2017 [monthly]

Terminated PHASE4
Jan 2017 — Feb 2017 [monthly]

Terminated PHASE4

First recorded

Nov 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute on Drug Abuse (NIDA)

Data source: National Institutes of Health Clinical Center (CC)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Baltimore, United States